Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Very well done p20, as usual!
Myself and others greatly appreciate YOU -- your in-depth knowledge/DD and factual information that you take the time to post Sir!
It's been a long time coming since the OTCM labeled us with a CE due to a friggin 3rd party social media postings! OTCM has yet to prove TXTM/company did anything wrong to warrant a Company/SH financial tragedy type label! Dr. J engaged immediately and proved TXTM did nothing wrong -- OTCM still could NOT provide any wrong doing by TXTM/company and yet OTCM let the CE remain for something that was out of the control of TXTM/company! So back then I said please tell OTCM go pound sand and bypass OTCM when ready! It looks like we may be very close to just that taking place and I pray he slams the OTCM crooks!
Big Mahalo's to you Sir!!!!
All the best,
R2R
Would the cost of insurance not be in the financials, thanks, I appeciate the response and agree with most
Would the cost of insurance not be in the financials, thanks, I appeciate the response and agree with most
Firstly, if I’m understanding your question correctly, I’m not sure how you derived that there is no insurance on our seeds, as it would defy logic. Dr. J and Dylon have repeatedly spoken directly about insuring and underwriting shipments, the farm, and all assets. So, the inference that there’s no insurance would go against all logic, especially for such a valuable asset.
The 15 million seeds were initially recorded on the books in an unaudited form. This strategic move helped the company likely avoid being declared a shell risk in late 2022 due to the CE application to the company. This classification could have brought additional regulatory scrutiny, so the company used the seed application to prevent that outcome.
In early 2024, the company underwent an audit as part of its annual report. This audit served several purposes, including likely laying the groundwork for an insurer or underwriter to evaluate the value of the company's assets—particularly the genetically stabilized seeds. The audit was performed under GAAP and likely IFRS standards, given the company’s plans for uplisting and its mention of the JSE and NYSE . With the audit providing verified numbers, it would then become possible for underwriters to step in, assess the operation, and offer insurance coverage for the assets. It's likely the seed assets were insured following the audit, given the need for clear, validated financial records to secure such coverage.
The seeds were officially valued at $1.00 per seed in the filings. This valuation was consistent across both the originally listed seeds and the donated seeds, which initially had no stated production value but were eventually assessed at the same $1.00 value. The $1.00 book value provides a baseline for accounting, but it doesn't reflect the actual worth of these seeds, which are genetically stabilized and pure strain. This kind of seed, especially with genetic stabilization, typically sells at prices exceeding $20 per seed in retail markets. However, these seeds are not intended for sale—they are part of the conglomerate's virtual seed bank, adding intrinsic long-term value beyond the book price.
This business model is similar to what Monsanto, now under Bayer, has implemented. Monsanto was a leader in developing genetically modified seeds and held numerous patents on their seed varieties. Rather than flooding the market with these seeds, Monsanto focused on controlling their distribution through in-house strategies. By doing so, they retained significant control over seed propagation and agricultural production, which allowed them to increase the value of their intellectual property. Monsanto’s strategy was to license their seed technologies selectively, which generated long-term revenue streams while keeping a tight grip on the genetics of their crops.
Keep in mind that TXTM is an acquisition company that can collateralize its assets, like the seeds, and leverage them to pursue acquisitions. This adds another layer of value, as the company’s assets can be used to generate growth through strategic transactions.
Comparisons made between TXTM’s seeds and general market seeds i've seen are severely flawed. There are virtually no large suppliers in the world that offer pure strain Genus Sativa seeds in bulk or otherwise, which is a key characteristic of TXTM’s assets. The unique nature of these seeds means a professional valuator would be required to properly assess their fair value, considering these distinctive traits.
Under GAAP, particularly ASC 905-330, agricultural products such as seeds can be valued at fair value when harvested. This value is determined based on market factors or production costs. For TXTM's seeds, which are genetically stabilized, winterized and proprietary, this means their fair value is significantly higher than typical market prices for regular seeds. IFRS, under IAS 41 Agriculture, aligns with this valuation approach, allowing biological assets like seeds to be recorded at fair value minus costs to sell, which supports the premium valuation assigned to these seeds due to their unique characteristics.
IMO the audit played crucial role in confirming the company’s valuation of the seeds. The verified valuation strengthens the company’s financial reporting and supports the underwriting and insurability of these assets. Auditors provide a critical assessment that insurers and underwriters rely on to determine asset coverage. In this case, the audit enables a professional valuator to assess the fair value of the seeds, which is likely far higher than the $1.00 book value reported in the filings. This assessment also serves as the foundation for future financial reports, insurance efforts, and potential uplisting plans, particularly on exchanges like the JSE and NYSE.
GLTU
oh my bad,assets are self insured, shipping etc..is different ball game.
GOOD LUCK
any questions? The tribesmen will shut you down and label you as Paid Basher or something 😂😂😂
what insurance you mean?if seeds go bad for example,or in general how they protect assets?
I appreciate your information so I don’t want this to sound like I am arguing. What is your take on no insurance on 100m in assets and also my research shows the total value of seeds grown last year globally is 150m ish, I have shitload of shares and I’m not selling but stuff like this does not make sense and it would help to have explanations for
MC at $16,000,000 with share price at $0.0016
THAT IS FACTS .. the rest is just .. a good night dream 😂😂
This is not an estimation, this is fact. Entire execution of multiplication contract occured in Q1. 100 million over 90 days.
$100 million in the bank in assets.
We have at least 4 crop cycles with numerous seed types this could be applied to at any time.
There is no mention of contract being terminated, or modified in any way. That would be a material event which must be dislosed. We have none.
I was referring to your comment about the supposed "generated assets at a rate of 1.1 million dollars per day" and its effect on TXTM's bottom line for the Next Quarterly Report. Should come out to about what in your estimation?
The quarterly is passed,and audited at that. So the pudding bowl is 100 million deep.
Looking forward to seeing the effect that has on the Quarterly Report. The proof is in the pudding.
TXTM is now generating assets at a rate of 1.1 million dollars per day. Whether you comprehend, accept, or understand the business model has no effect on that fact.
GLTU
Yes, there will be middle ground. But the crumbs left on the table from RSAMMD to TXTM will not be the crumbs that you are expecting.
Evidently the market does not buy into the spin certain TXTM shareholders are telling us. Rely on the Quarterly Reports, the rest is noise from the usual suspects.
10,000,000,000 X $0.0016=$16,000,000
Does this look like $100,000,000 to you ? 😂😂
There is a middle ground here as well, nothing is concrete and who knows what comes to fruition,and I don’t think it’s a scam either, throw some money in and see what happens, it’s a much safer play than the lottery. I feel like they will come through on some things that will increase shareholder value
As the next generation of bagholders is being crafted thru social media.
1. Name the global partnerships they have.
2. Kettle technology? C'mon already. That dead horse has been beaten enough. Show me TXTM kettle technology in usage.
3. Brics connection? Carbon Credits? Txtm ties? Once again, just more talk and assumption. Wishful thinking down the road is just wishful thinking. Don't confuse RSAMMD with TXTM.
It seems you’re missing the bigger picture when it comes to TXTM. TXTM is far from being a “charity for seed donations.” In fact, the company has a strategic and scalable business model that involves much more than what you’re suggesting.
Here are a few key points you might want to research:
1. Seed Multiplication Program: TXTM isn’t giving seeds away; they’re using their high-yield hemp seed multiplication strategy to increase production 20X per cycle. This will lead to massive scalability in the hemp and cannabis space, especially with their global partnerships.
2. Bioavailability Technology: TXTM is working on proprietary kettle technology that enhances the bioavailability of cannabinoids by up to 15X, making their products far superior to standard offerings on the market. This technology alone could revolutionize the hemp industry.
3. BRICS Connection: With TXTM’s deep ties to BRICS and upcoming blockchain integrations as DrJ has repeated time and time again, they are positioning themselves to be a global leader in the hemp and cannabis sectors, leveraging both their carbon credits and hemp-based biomass products.
Instead of spreading misinformation, I’d suggest digging deeper into TXTM’s growth strategy and realizing that quarter-over-quarter revenue isn’t the only measure of a company’s long-term value. TXTM’s positioning is far more strategic, and it’s aimed at major global markets.
If you don’t see the potential, maybe you’re just not looking hard enough.
20 billion AS over 12 billion OS and 200k dollars?
Vs
$100 million in asssets
Audited
Not even a contest.
There is revenue in ICNM, but how is that helping the stock price? No one wants any part of it. Our revenue will come in abundance. BTW, why are so focused on a stock that you are not even invested in.
The difference between the two is a significant quarter to quarter rise in real sales/revenue. ICNM is a company with a working business model, not a charity for seed donations.
Maybe yall need a better manager. All he does is tweet and then you come her talking about DJ TWEETING! The hypocrisy.
Management is top notch, but the Singapore based ICNM business plan is complex due to the nature of Industrial/Commercial AI expansion. Unfortunately, the results of the plans are dragging on beyond OTC trader's time frame. Hence the stagnant PPS.
You’ve been holding ICNM about as long as we have been holding TXTM. The difference is people can buy ICNM and it’s still stuck at .0003. Soooo, how reliable is the management over there. 🤣🤣🤣🤣
Remember when you point the finger, because three will point back at you. With that being said, that’s what you are hoping will happen with ICNM.🥴🥴🥴🥴
you apparently dumber than a box of beech rocks!How the fak anyone is gonna buy anything from anyone,when IT'S NOT TRADING!!!MUCH LESS PROFFIT!!!
Never happened, hence the CE. Current shareholders don't care about management credibility, they just want the Greater Fool to come along and buy their shares from them at a profit.
Blah blah blah blah…so, where’s the 2.3 mill pounds??
Great summary. Thank you!
Indeed, most have been affected by reverse splits (RS), myself included. There has been a clear pattern emerging since the beginning of the year. Dr. J has been retweeting every topic he has ever posted, and he has been fulfilling each one. Management has addressed the topic of reverse splits many times, and there will be no reverse split, ever. If you judge them by their actions, you have nothing to worry about. If you judge them by their long-term goals and the facts, our outstanding shares (OS), as illogical as it sounds, may be too small.
The exponential nature of their business model supports this notion. We have only seen the seed multiplication program applied to one seed, and that led to $100 million in assets so far, in just ONE crop cycle (3 months). That was only from Genus Sativa seeds.
Their tissue culture process, which is at the heart of the multiplication program, can be applied to ANY seed. This is a direct quote from management. What will that do? Apply it in parallel processes on MULTIPLE SEED VARIANTS simultaneously?!! Easily billions in asset generation alone per quarter is possible.The model has been proven
Then add in the cannabinoid extraction—what will that do? People also missed that this tech has seemingly exceeded 15x based on lab results Dr. J has posted, which unfortunately fell on deaf ears as well.
The facts and their actions have proven, at least to me, that they will fulfill their objectives without harm to their shareholders.
GLTU.
I do realize this. But I got hit with 2 RS. I just meant a RS to uplist which sometimes is a good thing if done right. No worries, jw. GL to us all!
Hopefully you realize only a moron would buy back shsres and then RS himself.
Hopefully no RS Is needed to achieve OTCQX .25 minimum bid price requirement
jse as second listing maybe,but that's just not an exchange people go,unless connected to region.Otherwise frankfurt is the place.
In my DD I saw that .25 which I liked but thought I saw some a further provision for lesser amount. Convoluted document. Hopefully I'm wrong.
You will get no rebuttal from me on any of those points. Except for the minimum bid price, which is $.25 for OTCQX Lets see what comes next!
GLTU
Per my DD, looks like OTCQX International is cheaper than uplisting to the NYSE, doesn't have a minimum share price if qualifiers are met, and CE removal is built-in somehow. Don't know what/why the JSE tweets. Like the sound of certain things done already! Prob shouldn't listen to me.😅🤪 IMO. GL all.
In my opinion, there are no scenarios where a spinoff would be necessary. In the long term, I foresee TXTM transitioning away from being a U.S.-based corporation. Given our current structure, there are clear advantages to onboarding into South Africa or continuing to leverage the U.S. Economic Empowerment Agreement with South Africa. This agreement offers access to favorable trade conditions, tax incentives, and emerging markets, which can significantly enhance TXTM’s growth strategy I stated in my post earlier today.
I have repeatedly stated that, due to what I believe to be tortious interference by OTCM, a completed and approved Form 10, along with applications for various exchanges, could already be in place, simply awaiting Dr. J’s approval for public disclosure. This could also explain the lack of reported revenue from the Hemp Order, which, in my opinion, was impacted for legal reasons. Even if this were not the case, there is nothing currently holding the company back. Full stop.
For a direct path to the NYSE, TXTM can demonstrate expected revenue that was impeded by OTCM’s interference and qualify with this anticipated revenue in conjunction with our $100 million in assets. The company would only need to provide proof of deliverability and production capacity to meet the necessary requirements to fulfill the Hemp Contract.
With regard to the OTCQX, we have been compelled to meet higher-tier requirements to remove the Caveat Emptor (CE) designation, which involved audits and additional injections, actions that may potentially violate FTC regulations. However, with completed PCAOB audits and a sponsor, the Form 10 could qualify us for listing on all U.S. exchanges.
As for the JSE, our auditor is IFRS compliant and is approved for submission to the JSE as a member of the Independent Regulatory Board for Auditors (IRBA). These IFRS audits may already qualify us for listing on the JSE, given that we now meet all the necessary requirements. A close examination of our GAAP filings clearly shows a dual listing in progress, as our assets are reported in both USD and ZAR (RAND).
While the SEC requires PCAOB audits under Sarbanes-Oxley for U.S.-based companies, our auditor, as previously noted, is a former director at PricewaterhouseCoopers. She could submit the audits to a firm like Pricewaterhouse, and under the AS 1204-1205 standard, they would likely be accepted. Why this has been such a large point of contention, I am unsure—it seems straightforward and easily achievable to me.
IMO there are no legal or listing criteria that I see preventing TXTM from meeting the requirements for any exchange globally.
GLTU
TXTM's Emerging Business Model:
A hybrid Holding-Banking-Acquisition-Distribution-Technology Conglomerate
What makes TXTM truly unique is how it’s been able to skip the toughest, most expensive stages of building a business. Thanks to the existing infrastructure provided by Leeds and its network of farms, TXTM didn’t have to start from scratch. This gave the company a head start, allowing it to focus on scaling and setting itself up to fully benefit from the profits.
Before dismissing the comparison to BlackRock and Berkshire Hathaway, take a closer look at their business models and compare them to what Dr. J and TXTM have already revealed. The parallels and the improvements TXTM has made are key to understanding why this company is different.
The real strength of TXTM lies in the scale of its operations, supported by Leeds and the infrastructure already in place, combined with the Human Capital of Dr. J. His experience give TXTM an edge in innovation and growth, making the company a real future contender in the market.
Another key factor is TXTM’s proprietary extraction technology. This technology gives the company a serious advantage, with higher retention rates and greater potency compared to its competitors. It’s not just efficient—it’s also cost-effective and likely far exceeding 15X initial target bio availability, which means TXTM is set to stand out in the market while boosting its profitability.
It’s time to really understand what TXTM is all about and how its business model works. Dr. J has taken inspiration from the best features of two industry giants—BlackRock and Berkshire Hathaway—and improved on them to create something even stronger for TXTM.
Rather than focusing on the size of BlackRock or Berkshire Hathaway, it's more important to examine the foundation of their business models and the challenges they face.
BlackRock’s approach, much like TXTM’s Bank model, revolves around managing a large portfolio of assets such as stocks, bonds, and real estate, all while incorporating advanced technology like blockchain. However, BlackRock's assets can be volatile. TXTM aims to improve on this by launching its own ETF—referred to as the "investor-managed fund" in tweets from 2022. By replacing volatile assets with stable, real-world ones and adding blockchain technology for transparency, TXTM reduces the risks while keeping the advantages of the model intact.
On the other hand, Berkshire Hathaway has built its success by owning stakes in a variety of businesses but letting them run independently. This has worked well for them, but their recent shift to converting stock holdings into cash shows a vulnerability during downturns. TXTM takes a different approach—while it will diversify like Berkshire, it will likely also keep direct control over its acquisitions, ensuring more oversight and flexibility to adapt quickly as it preforms the function of a holding company ( which it already is).
What really sets TXTM apart is Dr. J’s focus on innovation. These innovations, due to their scale, have the potential to become independent companies or be fully integrated into TXTM’s operations—just like the seed multiplication program. This kind of flexibility allows TXTM to grow both through acquisitions and by developing its own breakthroughs.
By blending acquisitions with internal innovations, TXTM has built a unique business model that combines the best of BlackRock’s financial expertise and Berkshire Hathaway’s diversification. At the same time, it’s pushing the boundaries with cutting-edge technology and scalable solutions.
The most recent "Tweets" hint at future developments and direction:
Scaling Operations: TXTM plans to expand its seed multiplication program by increasing partnerships and scaling production to meet the global demand for high-quality hemp seeds.
Global Market Penetration: The company aims to enter key international markets, particularly in Europe, Latin America, and Asia, forming strategic partnerships and distribution agreements.
Technological Application Beyond Hemp: TXTM is exploring how its patented cannabinoid extraction technology can be used on other crops, allowing the company to diversify its offerings and enter new agricultural sectors.
Metaverse Integration: TXTM is at the forefront of digital innovation, integrating its operations into the metaverse. By tokenizing book assets, customers can own fractional shares of production cycles, providing both digital engagement and new revenue opportunities.
Potential Uplisting: As part of its long-term strategy, TXTM is preparing for potential uplisting on major exchanges such as the NYSE/JSE, enabling access to capital markets for continued growth in both traditional and digital industries.
This is who we are and what we’re evolving into. $100 Million and counting...
GLTU
Not sure of your objective or what your thought process is. Are you trying to figure out the structure of TXTM or the paths to uplist and meet qualifications?
Holding co or typical self-contained co makes no difference. Thanks. IMO.
Understood. I don't see how the tweets from DrJ go together but I'm excited.
TXTM is an Aquisition Company. Always has been, always will be.
Could anyone point me to where in the financials the cost of the insurance is for these seeds? Surely if theres multi millions of dollars worth of seeds moisture damage rodents bugs there will be a hi insurance bill? And who is actually valuing these seeds at 100 mill is there a registered valuation from a expert or is this coming from the DOC j
Asking for a friend 🤔
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |